Status:

UNKNOWN

Use of Sodium Bicarbonate in Patients Treated With Topiramate

Lead Sponsor:

McMaster Children's Hospital

Conditions:

Epilepsy

Metabolic Acidosis

Eligibility:

All Genders

2-18 years

Phase:

NA

Brief Summary

Effect of oral sodium bicarbonate therapy on renal tubular acidosis in epilepsy patients taking topiramate.

Detailed Description

Children on topiramate are at a risk of renal tubular acidosis and subsequent development of renal stones. Sodium bicarbonate has been shown to reduce renal tubular acidosis in other populations. To d...

Eligibility Criteria

Inclusion

  • Patients with epilepsy receiving oral topiramate for a minimum of 3 months

Exclusion

  • pre-existing renal impairments (ie nephropathy, primary nephritis)
  • receiving other medications or diet therapies that may influence renal function or urine acidity/ citrate concentration

Key Trial Info

Start Date :

January 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2018

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03354507

Start Date

January 1 2018

End Date

December 1 2018

Last Update

November 28 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

McMaster Children's Hospital

Hamilton, Ontario, Canada, L8N 3Z5

Use of Sodium Bicarbonate in Patients Treated With Topiramate | DecenTrialz